药品流通监管重点与科学监管方法探讨  

Discussion on Emphases and Scientific Method of Supervision of Drug Distribution

作　　者：赖晓欣 何磊 毛颖新 何海鸥 

机构地区：[1]深圳市食品药品监督管理局,深圳518035

出　　处：《中国药事》2008年第11期950-953,共4页Chinese Pharmaceutical Affairs

基　　金：卫生部医药卫生科技项目(编号:440430081234)

摘　　要：针对药品批发企业对医疗机构的药品配送,即对医疗机构使用药品的数据加以分析,研究药品的流通特性与医疗机构的关系、药品与使用者的关系、药品成本与质量的关系,从中找出药品流通领域应监管的重点药品品种、品规及重点单位,提高监管的针对性和决策的科学性,为在药品流通市场建立预防性和针对性相结合的监督管理体系提供科学依据。Based on data of drugs distributed by pharmaceutical whole enterprises to medical institutions, i.e. drugs used by medical institutions. Analyzed the underlying preference of medical institutions in drug selection, and the relationship between drugs and drug users, drug cost and quality. To conclude, it presents the types, specifications of drugs and drugs users which should be under key supervision in the pharmaceutical distribution market and a preventive and well-targeted supervision and management system for drug distribution.

关 键 词：药品流通 使用分析 监管重点 监管方法(流通环节) 

分 类 号：R95[医药卫生—药学]